GETECCU|Publicaciones generadas por el Grupo Joven

Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.

Barreiro-de Acosta M, García-Bosch O, Gordillo J, Mañosa M, Menchén L, Souto R, Marin-Jimenez I.Grupo Joven GETECCU. Eur J Gastroenterol Hepatol. 2012 Jul;24(7):756-8

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.

Barreiro-de Acosta M, García-Bosch O, Souto R, Mañosa M, Miranda J, García-Sanchez V, Gordillo J, Chacon S, Loras C, Carpio D, Maroto N, Menchén L, Rojas-Feria M, Sierra M, Villoria A, Marin-Jimenez I; Grupo joven GETECCU.Inflamm Bowel Dis. 2012 May;18(5):812-7

High smoking cessation rate in Crohn’s disease patients after physician advice- the TABACROHN Study

Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Martí E, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU. J Crohns Colitis. 2013 Apr;7(3):202-7

Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study

Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU, Spanish Working Group in Crohn’s Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2013 Jan;19(1):23-9

última actualización: 13 de julio de 2018 09:40
Nuestros patrocinadores|lea nuestra política de patrocinio